1. Home
  2. IKNA vs IDN Comparison

IKNA vs IDN Comparison

Compare IKNA & IDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IKNA
  • IDN
  • Stock Information
  • Founded
  • IKNA 2016
  • IDN 1994
  • Country
  • IKNA United States
  • IDN United States
  • Employees
  • IKNA N/A
  • IDN N/A
  • Industry
  • IKNA Biotechnology: Pharmaceutical Preparations
  • IDN Computer Software: Prepackaged Software
  • Sector
  • IKNA Health Care
  • IDN Technology
  • Exchange
  • IKNA Nasdaq
  • IDN Nasdaq
  • Market Cap
  • IKNA 61.8M
  • IDN 50.8M
  • IPO Year
  • IKNA 2021
  • IDN 1999
  • Fundamental
  • Price
  • IKNA $1.11
  • IDN $2.43
  • Analyst Decision
  • IKNA Buy
  • IDN Buy
  • Analyst Count
  • IKNA 2
  • IDN 2
  • Target Price
  • IKNA $3.00
  • IDN $3.00
  • AVG Volume (30 Days)
  • IKNA 84.2K
  • IDN 103.2K
  • Earning Date
  • IKNA 05-12-2025
  • IDN 05-12-2025
  • Dividend Yield
  • IKNA N/A
  • IDN N/A
  • EPS Growth
  • IKNA N/A
  • IDN N/A
  • EPS
  • IKNA N/A
  • IDN N/A
  • Revenue
  • IKNA N/A
  • IDN $19,997,000.00
  • Revenue This Year
  • IKNA N/A
  • IDN $7.60
  • Revenue Next Year
  • IKNA N/A
  • IDN $10.02
  • P/E Ratio
  • IKNA N/A
  • IDN N/A
  • Revenue Growth
  • IKNA N/A
  • IDN 5.77
  • 52 Week Low
  • IKNA $0.97
  • IDN $1.92
  • 52 Week High
  • IKNA $1.94
  • IDN $4.46
  • Technical
  • Relative Strength Index (RSI)
  • IKNA 38.47
  • IDN 46.11
  • Support Level
  • IKNA $1.06
  • IDN $2.28
  • Resistance Level
  • IKNA $1.25
  • IDN $2.54
  • Average True Range (ATR)
  • IKNA 0.10
  • IDN 0.23
  • MACD
  • IKNA 0.00
  • IDN -0.02
  • Stochastic Oscillator
  • IKNA 39.83
  • IDN 24.07

About IKNA Ikena Oncology Inc.

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.

About IDN Intellicheck Inc.

Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The company makes it possible for its clients to increase revenues, improve customer service, and increase operational efficiencies. Under the new direction, the company is focused on partnering with banks credit card issuers, and retailers to prevent fraud. It derives revenue through Sales of systems, subscription fees, Sale of software upgrades, and extended maintenance programs.

Share on Social Networks: